BSE
NSE

NSE Prices delayed by 15 minutes ! Prices as on Mar 23, 2026

ABB India 6041.5 [ -4.06% ]
ACC 1329.8 [ -3.74% ]
Ambuja Cements 395.35 [ -5.99% ]
Asian Paints 2121.3 [ -3.38% ]
Axis Bank 1170.6 [ -2.77% ]
Bajaj Auto 8776 [ -3.04% ]
Bank of Baroda 265.9 [ -5.02% ]
Bharti Airtel 1795.9 [ -2.72% ]
Bharat Heavy 252.85 [ -3.51% ]
Bharat Petroleum 271.3 [ -5.73% ]
Britannia Industries 5490 [ -2.29% ]
Cipla 1221.8 [ -2.75% ]
Coal India 455.25 [ -2.76% ]
Colgate Palm 1849.2 [ -2.47% ]
Dabur India 417.35 [ -3.10% ]
DLF 514.75 [ -4.81% ]
Dr. Reddy's Lab. 1253.3 [ -3.51% ]
GAIL (India) 135.4 [ -5.23% ]
Grasim Industries 2531.1 [ -3.26% ]
HCL Technologies 1358.6 [ 1.87% ]
HDFC Bank 744.15 [ -4.65% ]
Hero MotoCorp 5065 [ -3.99% ]
Hindustan Unilever 2052.2 [ -1.46% ]
Hindalco Industries 840.25 [ -3.89% ]
ICICI Bank 1222.7 [ -1.82% ]
Indian Hotels Co. 582.45 [ -5.38% ]
IndusInd Bank 778.35 [ -4.92% ]
Infosys 1256.8 [ 0.07% ]
ITC 290.45 [ -3.17% ]
Jindal Steel 1106.2 [ -6.77% ]
Kotak Mahindra Bank 356.55 [ -2.78% ]
L&T 3342.4 [ -2.69% ]
Lupin 2296.7 [ -1.11% ]
Mahi. & Mahi 2955.8 [ -3.60% ]
Maruti Suzuki India 12355 [ -1.95% ]
MTNL 23.25 [ -6.06% ]
Nestle India 1166.8 [ -2.25% ]
NIIT 54.36 [ -8.96% ]
NMDC 75.09 [ -5.88% ]
NTPC 372.4 [ -2.24% ]
ONGC 265.45 [ 0.02% ]
Punj. NationlBak 105.55 [ -5.36% ]
Power Grid Corpn. 302.1 [ 1.51% ]
Reliance Industries 1407.8 [ -0.47% ]
SBI 1031.9 [ -2.47% ]
Vedanta 645.75 [ -3.93% ]
Shipping Corpn. 219.15 [ -6.09% ]
Sun Pharmaceutical 1758.4 [ -1.05% ]
Tata Chemicals 608.85 [ -3.86% ]
Tata Consumer 1023.6 [ -2.53% ]
Tata Motors Passenge 305.25 [ -2.82% ]
Tata Steel 187.17 [ -4.88% ]
Tata Power Co. 386.95 [ -3.84% ]
Tata Consult. Serv. 2383.8 [ -0.28% ]
Tech Mahindra 1384 [ -0.06% ]
UltraTech Cement 10362 [ -5.23% ]
United Spirits 1275.2 [ -1.92% ]
Wipro 187.54 [ -1.76% ]
Zee Entertainment 68.39 [ -6.03% ]

Partner with US

Open an Demat Account

Portfolio Tracker

News Details
Home

News Details

19/03/2026 17:33

Back

Cipla - Outcome of Board Meeting

Cipla Limited has informed the Exchange regarding Outcome of Board Meeting held on March 19, 2026 regarding:1. Approved investment upto USD 100 million in the equity share capital of Cipla (EU) Limited, a whollyowned subsidiary of the Company for the purpose of providing onward financial assistance to InvaGen Pharmaceuticals Inc., wholly-owned subsidiary of Cipla (EU) Limited, to meet its capital expenditure, working capital requirements and other general corporate purposes.2. Approved Scheme of Amalgamation of Inzpera Healthsciences Limited ( Transferor Company ), wholly owned subsidiary with the Company ( Transferee Company ). The Scheme of Amalgamation is subject to necessary approvals required under the Companies Act, 2013, including approval of the Hon bleNational Company Law Tribunal, Mumbai. The proposed amalgamation will not have any material impact on the financials of the Company.